[25-NSE] Verve Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Perma-Fix Environmental Services, Inc. (PESI) filed a Form 4 reporting a routine equity-compensation grant to non-employee director Joe Reeder on 07/24/2025.

• Type of security: Non-qualified stock option covering 10,000 shares of PESI common stock.
• Exercise price: $12.23 per share.
• Vesting schedule: 25% per year over four years under the 2003 Outside Directors Stock Plan.
• Expiration date: 07/24/2035.
• Ownership form: Direct; no common-stock acquisitions or dispositions were reported.

No cash transaction occurred, and the filing introduces no immediate earnings or cash-flow effects. The event is considered routine director compensation with limited near-term impact on shareholders.

Insights

Securities Analyst

TL;DR: Routine option grant; negligible near-term financial impact.

The Form 4 details a standard 10,000-share option award to director Joe Reeder at a $12.23 strike. Because the award vests over four years and is not exercised, PESI’s share count and cash position remain unchanged. The filing does not signal insider bullishness or concern—no open-market purchase or sale occurred. Investors should treat this as neutral housekeeping rather than a catalyst.

Corporate Governance Expert

TL;DR: Option aligns director incentives; governance-neutral.

Granting stock options to outside directors is common practice to link board interests with shareholder value. The four-year vesting promotes long-term oversight. Neither excessive size nor unusual terms are evident, so the grant appears consistent with best-practice compensation policies. Governance risk is minimal.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

333-256608

Issuer:	Verve Therapeutics, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	201 Brookline Avenue, Suite 601
	Boston	MASSACHUSETTS	02215
Telephone number:					(617) 603-0070

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-07-25	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity was disclosed for PESI?

Director Joe Reeder received 10,000 stock options on 07/24/2025 at a $12.23 strike price.

Does the Form 4 show any PESI stock being bought or sold?

No. The filing reports only an option grant; no common-stock transactions occurred.

When do the new PESI options vest?

The options vest in four equal annual installments—25% each year—starting from the grant date.

When do the PESI director options expire?

The options expire on 07/24/2035 unless exercised earlier.

Is this option grant material to Perma-Fix investors?

The award is considered routine director compensation and is unlikely to be financially material in the short term.